178 related articles for article (PubMed ID: 33246951)
21. Synthesis and Characterization of a Biocomposite Bone Bandage for Controlled Delivery of Bone-Active Drugs in Fracture Nonunions.
Raina DB; Glencross A; Chaher N; Liu Y; Lidgren L; Isaksson H; Tägil M
ACS Biomater Sci Eng; 2020 May; 6(5):2867-2878. PubMed ID: 33463281
[TBL] [Abstract][Full Text] [Related]
22. Repair of rat cranial bone defects with nHAC/PLLA and BMP-2-related peptide or rhBMP-2.
Li J; Hong J; Zheng Q; Guo X; Lan S; Cui F; Pan H; Zou Z; Chen C
J Orthop Res; 2011 Nov; 29(11):1745-52. PubMed ID: 21500252
[TBL] [Abstract][Full Text] [Related]
23. Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model.
Kodera R; Miyazaki M; Yoshiiwa T; Kawano M; Kaku N; Tsumura H
Bone; 2014 Jan; 58():26-32. PubMed ID: 24103577
[TBL] [Abstract][Full Text] [Related]
24. Effect of antibiotic infused calcium sulfate/hydroxyapatite (CAS/HA) insets on implant-associated osteitis in a femur fracture model in mice.
Oezel L; Büren C; Scholz AO; Windolf J; Windolf CD
PLoS One; 2019; 14(3):e0213590. PubMed ID: 30870491
[TBL] [Abstract][Full Text] [Related]
25. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect.
Bougioukli S; Jain A; Sugiyama O; Tinsley BA; Tang AH; Tan MH; Adams DJ; Kostenuik PJ; Lieberman JR
Bone; 2016 Mar; 84():93-103. PubMed ID: 26723577
[TBL] [Abstract][Full Text] [Related]
26. Dual modulation of bone formation and resorption with zoledronic acid-loaded biodegradable magnesium alloy implants improves osteoporotic fracture healing: An in vitro and in vivo study.
Li G; Zhang L; Wang L; Yuan G; Dai K; Pei J; Hao Y
Acta Biomater; 2018 Jan; 65():486-500. PubMed ID: 29079514
[TBL] [Abstract][Full Text] [Related]
27. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model.
Tinsley BA; Dukas A; Pensak MJ; Adams DJ; Tang AH; Ominsky MS; Ke HZ; Lieberman JR
J Bone Joint Surg Am; 2015 Nov; 97(22):1852-9. PubMed ID: 26582615
[TBL] [Abstract][Full Text] [Related]
28. Spatial control of bone formation using a porous polymer scaffold co-delivering anabolic rhBMP-2 and anti-resorptive agents.
Yu NY; Gdalevitch M; Murphy CM; Mikulec K; Peacock L; Fitzpatrick J; Cantrill LC; Ruys AJ; Cooper-White JJ; Little DG; Schindeler A
Eur Cell Mater; 2014 Jan; 27():98-109; discussion 109-111. PubMed ID: 24488823
[TBL] [Abstract][Full Text] [Related]
29. Hydroxyapatite granule graft combined with recombinant human bone morphogenic protein-2 for solid lumbar fusion.
Konishi S; Nakamura H; Seki M; Nagayama R; Yamano Y
J Spinal Disord Tech; 2002 Jun; 15(3):237-44. PubMed ID: 12131427
[TBL] [Abstract][Full Text] [Related]
30. The effect of locally delivered recombinant human bone morphogenetic protein-2 with hydroxyapatite/tri-calcium phosphate on the biomechanical properties of bone in diabetes-related osteoporosis.
Liporace FA; Breitbart EA; Yoon RS; Doyle E; Paglia DN; Lin S
J Orthop Traumatol; 2015 Jun; 16(2):151-9. PubMed ID: 25421865
[TBL] [Abstract][Full Text] [Related]
31. Preparation of Coralline Hydroxyapatite Implant with Recombinant Human Bone Morphogenetic Protein-2-Loaded Chitosan Nanospheres and Its Osteogenic Efficacy.
Xia YJ; Wang W; Xia H; Huang XH; Deng FP; Ying QS; Yu X; Li LH; Wang JH; Zhang Y
Orthop Surg; 2020 Dec; 12(6):1947-1953. PubMed ID: 33080108
[TBL] [Abstract][Full Text] [Related]
32. Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation.
Yu NY; Schindeler A; Peacock L; Mikulec K; Fitzpatrick J; Ruys AJ; Cooper-White JJ; Little DG
Eur Cell Mater; 2013 Feb; 25():190-203. PubMed ID: 23444237
[TBL] [Abstract][Full Text] [Related]
33. BMP-2 delivered via sucrose acetate isobutyrate (SAIB) improves bone repair in a rat open fracture model.
Cheng TL; Schindeler A; Little DG
J Orthop Res; 2016 Jul; 34(7):1168-76. PubMed ID: 26679381
[TBL] [Abstract][Full Text] [Related]
34. Long-term controlled delivery of rhBMP-2 from collagen-hydroxyapatite scaffolds for superior bone tissue regeneration.
Quinlan E; Thompson EM; Matsiko A; O'Brien FJ; López-Noriega A
J Control Release; 2015 Jun; 207():112-9. PubMed ID: 25817394
[TBL] [Abstract][Full Text] [Related]
35. Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery system for bone repair.
Keskin DS; Tezcaner A; Korkusuz P; Korkusuz F; Hasirci V
Biomaterials; 2005 Jun; 26(18):4023-34. PubMed ID: 15626448
[TBL] [Abstract][Full Text] [Related]
36. A collagen-hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates.
Murphy CM; Schindeler A; Gleeson JP; Yu NY; Cantrill LC; Mikulec K; Peacock L; O'Brien FJ; Little DG
Acta Biomater; 2014 May; 10(5):2250-8. PubMed ID: 24456759
[TBL] [Abstract][Full Text] [Related]
37. Investigating the synergistic efficacy of BMP-7 and zoledronate on bone allografts using an open rat osteotomy model.
Mathavan N; Bosemark P; Isaksson H; Tägil M
Bone; 2013 Oct; 56(2):440-8. PubMed ID: 23845325
[TBL] [Abstract][Full Text] [Related]
38. Templated repair of long bone defects in rats with bioactive spiral-wrapped electrospun amphiphilic polymer/hydroxyapatite scaffolds.
Kutikov AB; Skelly JD; Ayers DC; Song J
ACS Appl Mater Interfaces; 2015 Mar; 7(8):4890-901. PubMed ID: 25695310
[TBL] [Abstract][Full Text] [Related]
39. Bioinspired trimodal macro/micro/nano-porous scaffolds loading rhBMP-2 for complete regeneration of critical size bone defect.
Tang W; Lin D; Yu Y; Niu H; Guo H; Yuan Y; Liu C
Acta Biomater; 2016 Mar; 32():309-323. PubMed ID: 26689464
[TBL] [Abstract][Full Text] [Related]
40. Delivery systems for BMPs: factors contributing to protein retention at an application site.
Uludag H; Gao T; Porter TJ; Friess W; Wozney JM
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S128-35. PubMed ID: 11314790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
